文献速递外周动脉疾病

广泛髂股动脉闭塞性病变的杂交血运重建

Hybrid Revascularization for Extensive Iliofemoral Occlusive Disease.
PubMed 文献 · Ann Vasc Surg · 2022-09-02

研究回顾了2013年1月至2018年12月在赫尔辛基大学医院进行的147例患者共163处髂股动脉闭塞的杂交血运重建(股动脉内膜剥脱术联合髂动脉闭塞再通),技术成功率88.3%,30天、6个月、1年、2年一期通畅率分别为98.7%、98.1%、96.6%、93.7%,结论为可获得良好的即刻成功率和中期通畅率,需仔细选择患者。

要点

  • 杂交血运重建(股动脉内膜剥脱+髂动脉再通)技术成功率88.3%。
  • 2年一期通畅率93.7%,围手术期重大心血管事件或卒中发生率8.1%。
  • 主动脉受累是长期通畅率较差的显著决定因素,但不妨碍技术成功。

核心结论

  • 对髂股动脉闭塞行杂交血运重建可获得良好的即刻成功率和中期通畅率。
  • 必须仔细选择患者,因为该人群常合并全身性动脉粥样硬化。
  • 主动脉受累是长期通畅率较差的显著决定因素,但不妨碍技术成功。

研究设计与样本

  • 回顾性综述,纳入2013年1月至2018年12月在赫尔辛基大学医院因髂股动脉闭塞行股动脉内膜剥脱联合髂动脉闭塞腔内治疗的杂交血运重建。
  • 共147例患者、163处髂股动脉闭塞。
  • 2019年11月通过随访对中期通畅率进行前瞻性评估。

主要发现

  • 6例(3.6%)为肾下主动脉闭塞,86例(52.7%)为髂总动脉闭塞,128例(78.5%)为髂外动脉闭塞。
  • 技术成功率为88.3%(144处闭塞再通);病变≥90 mm者一期技术成功率为87.1%,短于90 mm者为95.7%(χ2 P=0.06)。
  • 141例(94.6%)置入髂动脉支架,其中51例(34.3%)为覆膜支架;1.2%的病例残留显著狭窄。
  • 中位手术时间4小时34分钟(四分位距2小时43分钟),中位估计失血量743 mL(四分位距500 mL)。
  • 5例(3.0%)发生腹股沟深部感染,12例(8.1%)围手术期发生重大心血管事件或卒中。

临床怎么用

  • 对症状性缺血肢体应努力行血运重建,杂交血运重建(股动脉内膜剥脱联合髂动脉闭塞再通)是可选方案之一。
  • 作者认为必须仔细选择患者,因为该人群常合并全身性动脉粥样硬化;主动脉受累是长期通畅率较差的显著决定因素,但不妨碍技术成功。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total occlusion of the iliac-femoral tract can cause a variety of life-limiting symptoms ranging from mild claudication to chronic limb-threatening ischemia. Efforts should be made to revascularize the symptomatic ischemic limb. Currently there are different options in the vascular surgeon's armamentarium to achieve this. The aim of the study was to verify the feasibility and outcomes of inflow hybrid revascularizations combining femoral endarterectomy and recanalization of iliac atherosclerotic occlusion. METHODS: A retrospective review was conducted of all hybrid revascularizations involving femoral endarterectomy and endovascular treatment of iliac occlusion. The operations were performed in Helsinki University Hospital between January 2013 and December 2018. First, information about patients' baseline characteristics, indications and details of surgery and technical/hemodynamic success, and complications and mortality were obtained from the vascular registry and patients records. Secondarily, a prospective assessment of mid-term patency was performed through follow-up in November 2019. Immediate technical success, 30-day mortality, complications, and patency were considered major outcomes. Hemodynamic improvement, amputation rate, and overall mortality were also assessed. RESULTS: One hundred sixty three iliofemoral occlusions were performed on 147 patients during the period studied. Six patients (3.6%) had infrarenal aortic occlusion, 86 (52.7%) had common iliac, and 128 (78.5%) had external iliac artery occlusion. Technical success rate was 88.3% (n = 144 occlusions recanalized). Primary technical success was somewhat lower in lesions ≥ 90 mm (87.1%) compared to lesions shorter than 90 mm (95.7%; χ2P = 0.06). Iliac stent was deployed in 141 (94.6%) cases, 51 (34.3%) of which were covered stents. Significant residual stenosis remained in 1.2% of cases. Median operative time was 4 hr 34 min (interquartile range 2 hr 43 min) and median estimated blood loss was 743 mL (interquartile range 500 mL). Five patients (3.0%) developed a deep groin infection and 12 (8.1%) suffered any major cardiovascular event or stroke perioperatively. Primary patency at 30 day, 6 months, 1 year, and 2 years was 98.7%, 98.1%, 96.6%, and 93.7%, respectively. Hemodynamic success was documented in 107 patients (73%). By the end of the follow-up, 7 iliofemoral tracts (11.1%) reoccluded, 2 limbs (1.2%) required amputation, and 50 patients (3.0%) died. CONCLUSIONS: Good immediate success rate and mid-term patency can be achieved by hybrid revascularization of iliofemoral occlusions. Careful patient selection is mandatory because this population often suffers from universal atherosclerosis. The involvement of the aorta represents a significant determinant of worse long-term patency, although it did not preclude technical success.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Serna Santos J, Laukontaus S, Laine M, et al. Hybrid Revascularization for Extensive Iliofemoral Occlusive Disease. Ann Vasc Surg. 2022. PMID: 36058456. doi:10.1016/j.avsg.2022.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。